LECAP Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
LECAP Asset Management's CORT Position: Q3 2026 in Review
LECAP Asset Management opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 5,458 shares worth $629K. The stake represents 0.3% of the portfolio and ranks #142 among its holdings.
503 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- LECAP Asset Management held 5,458 shares of Corcept Therapeutics worth $629K as of Q3 2026.
- Corcept Therapeutics was a new LECAP Asset Management position in Q3 2026.
- Corcept Therapeutics made up 0.3% of LECAP Asset Management's portfolio in Q3 2026, its #142 holding.
- 503 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on LECAP Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.